Skip to main content
Clinical Trials/NL-OMON32679
NL-OMON32679
Recruiting
Not Applicable

Pharmacokinetics and pharmacodynamics of drugs for Nontuberculous Mycobacterial diseases in Dutch patients - PK and PD of drugs for Nontuberculous Mycobacterial diseases

niversitair Medisch Centrum Sint Radboud0 sites26 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
non tuberculous mycobacteria
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
26
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • Currently treated for NTM infection or recently diagnosed with NTM infection starting treatment at ULC Dekkerswald, Groesbeek, or Centre for Revalidation Beatrixoord, Haren, the Netherlands.
  • Diagnosis and treatment according to ATS criteria for NTM infections. Patients with pulmonary (eventually with extrapulmonary localizations) NTM infections are eligible.
  • Treated with at least rifampicin and ethambutol and optionally with claritromycin or azitromycin on a daily basis.
  • Age \>\=18 years.
  • Patient has been using drugs for at least two weeks when steady state concentrations of rifampicin and azithromycin is expected.
  • Informed consent has been signed.

Exclusion Criteria

  • The medical state of the patients does not allow inclusion according to the physician in attendance.
  • The patients\* clinical parameters urge immediate cessation of drugs.
  • The patient is pregnant.
  • Significant hepatic or renal dysfunction
  • Patients with cystic fibrosis, since these show deviating pharmacokinetics for many drugs.
  • Patients with HIV infection

Outcomes

Primary Outcomes

Not specified

Similar Trials